RDIF launches coronavirus diagnostics in Russia using CT scans combined with artificial intelligence technology

Press release, 24.04.2020

Moscow, April 24, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announces the launch of a project to diagnose and detect pneumonia, including that caused by the SARS-COV-2 coronavirus, using CT scans combined with Russian-UAE artificial intelligence (AI) technology developed in partnership between Group 42 (G42), UAE’s leading technology company, RDIF and Medscan Group, Russian network of medical centres.

The Russian-UAE AI technology is more than 96% accurate with a high sensitivity to detect signatures of pneumonia. It has been tested on numerous patients with suspected SARS-COV-2 coronavirus in Hubei Province, China. The system enables automatic pneumonia detection within 1-2 minutes after taking the picture. The analysis of the CT scans will be processed exclusively on computer servers in Russia in accordance with national legislation.

To implement the project, RDIF has created a joint venture (JV) with Medscan, a network of Russian medical centres, specializing in radiology and laboratory diagnosis, and treatment of cancer using radiation and drug therapy. Within the framework of the RDIF and Medscan partnership, the All-Russian Competence Centre for remote analysis and recognition of CT scans using AI technologies will be created. Several leading Russian private and state multidisciplinary clinics have already shown interest in using the JV’s technologies.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said:
“Highly accurate and timely diagnosis of coronavirus infection is one of the keys to a successful fight against the virus. The Russian-UAE AI technology allows quick and very accurate determination of the patient’s status, which significantly increases the efficiency of the diagnosis and treatment of coronavirus. Medscan’s experience in introducing advanced diagnostic systems and developing modern approaches to managing health risks will help reduce the negative impact of coronavirus infection in Russia.”

Evgeny Tugolukov, founder of Medscan Group, noted:
“Medscan Group has always considered the introduction of advanced international technologies in Russia as a priority. We are confident Russia can make full use of international experience thanks to RDIF’s wide network of partnerships, supplemented with domestic developments. Our joint efforts with RDIF will ultimately enable Russian doctors to provide patients with high-quality medical care.”


Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB1.8 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 15 countries that total more than $40 bn.

RDIF takes active steps to counteract COVID-19:

  • Jointly with the ChemRar Group, RDIF is launching the production of Favipiravir, a drug that has proven effective in the treatment of infected patients in China;
  • Jointly with Japan’s K.K. Mirai Genomics, RDIF has invested in the production and distribution of the Russian-Japanese diagnostic system EMG - Evotech-Mirai Genomics, which is one the world’s most accurate and fastest systems for the detection of coronavirus. Results are achieved in just 30 minutes. A range of testing systems has been adapted for use in both fixed laboratories and unique portable mini-laboratories (the size of a small suitcase) which can be used anywhere, including hospitals and public institutions such as schools, offices, airports and train stations.
  • RDIF was one of the initiators of the Alliance against coronavirus, which also includes the Russian Union of Industrialists and Entrepreneurs (RUIE), Yandex, Mail.ru Group and the Rossiya Segodnya international news agency;
  • Alongside Rossiya Segodnya, RDIF has published a unique “Handbook of COVID-19 Prevention and Treatment”, based on China’s experience in the fight against coronavirus. The Handbook is available at: https://rdif.ru/data/file/COVID_19_Book.pdf

Further information can be found at rdif.ru

For additional information contact:
Arseniy Palagin
Russian Direct Investment Fund
Press Secretary
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41
E-mail: arseniy.palagin@rdif.ru

Andrew Leach / Maria Shiryaevskaya
Hudson Sandler
Tel: +44 (0) 20 7796 4133